Robert Busard Brown serves as Executive at Brickell Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Robert Busard Brown has executed 2 insider transactions totaling $118.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 15, 2021 involved purchasing 100,000 shares valued at $118.0K.
Robert Busard Brown currently holds 186,957 shares of Brickell Biotech, Inc. (BBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Busard Brown has been a net buyer of BBI stock. They have purchased $118.0K and sold $0 worth of shares.
Robert Busard Brown's most recent insider trade was on Mar 15, 2021, when they purchased 100,000 shares at $1.18 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |